Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Vestn Otorinolaringol ; 86(4): 73-78, 2021.
Article in Russian | MEDLINE | ID: mdl-34499452

ABSTRACT

Cystic fibrosis is genetic multisystem disorder with a predominant lesion of the respiratory tract. The duration and quality of life of these patients depends on the state of respiratory function. Progressive lung dysfunction is still the leading cause of mortality patients with cystic fibrosis. End-stage lung diseases in patients with cystic fibrosis, lung transplantation is a viable method of treatment. It has the ability to prolong life of these patients. Survival in cystic fibrosis has steadily increased medical treatment and post-transplant. Chronic rhinosinusitis (with nasal polys and without) impacts almost all cystic fibrosis patients, leading to significant reductions in quality of life. Chronic rhinosinusitis with nasal polyps is prevalent in the cystic fibrosis patients, and it is often a recalcitrant infection with multidrug resistant organisms. Medical therapies such as nasal irrigations, nasal steroids, and antibiotics are critical for managing symptoms, but functional endoscopic sinus surgery is necessary for refractory cases. The unified airway hypothesis suggests that sanitation bacterial infection in the upper airway can also decrease bacterial burden in the lungs. The article presents a clinical case of successful endoscopic sinus surgery in a 15-year-old patient with chronic rhinosinusitis with nasal polyps and cystic fibrosis after lung transplantation. The intervention was performed under General anesthesia and controlled hypotension. Bilateral antrostomy, ethmoidectomy and Draf IIb frontal sinusotomy were performed by endoscopic endonasal approach. There were no intra - and post-operative rhinosurgical or lung complications. The follow-up period was 18 months. At present, there is no relapse of chronic polypous rhinosinusitis, and there are no indications for revision intervention.


Subject(s)
Cystic Fibrosis , Lung Transplantation , Nasal Polyps , Rhinitis , Sinusitis , Adolescent , Chronic Disease , Cystic Fibrosis/complications , Cystic Fibrosis/surgery , Endoscopy , Humans , Lung Transplantation/adverse effects , Quality of Life , Rhinitis/complications , Rhinitis/diagnosis , Sinusitis/complications , Sinusitis/diagnosis
2.
Probl Endokrinol (Mosk) ; 65(1): 39-45, 2019 05 14.
Article in Russian | MEDLINE | ID: mdl-31091049

ABSTRACT

We report a case of cerebral salt-wasting syndrome in a 12-year-old boy with severe traumatic brain injury. The child developed refractory intracranial hypertension at the time of injury, which required decompressive craniectomy on the 7th day after injury. Infusion of hypertonic sodium chloride solutions performed at the intensive care unit resulted in hypernatremia on the 5th day and polyuria and hypovolemia on the 11th day, which was regarded as manifestations of central diabetes insipidus. Persistent hyponatremia developed on the 17th day after injury; on the next day, the therapy was supplemented with Fludrocortisone at a dose of 100 µg/day, followed by an increase in the dose to 150 µg/day, which had no significant effect. Fludrocortisone was discontinued on the 30th day of therapy, but it was re-used at a dose of 400 µg/day from the 54th day. During this treatment, polyuria gradually decreased to 4 to 5 l/day, and the plasma sodium concentration remained within the reference values. The dose of Fludrocortisone was increased to 600 µg/day since the 66th day. The child was transferred to a specialized department on the 67th day after injury. At the Department of Neurosurgery, the dose of Cortineff was gradually reduced starting with the 94th day and completely discontinued on the 122nd day after injury. On day 132th of the post-traumatic period, the patient was transferred to another hospital for rehabilitation therapy.


Subject(s)
Brain Injuries, Traumatic/pathology , Hyponatremia/etiology , Polyuria/etiology , Sodium/blood , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Brain Injuries, Traumatic/blood , Brain Injuries, Traumatic/complications , Child , Fludrocortisone/administration & dosage , Fludrocortisone/analogs & derivatives , Fludrocortisone/therapeutic use , Humans , Hyponatremia/drug therapy , Male , Polyuria/drug therapy
3.
Zh Nevrol Psikhiatr Im S S Korsakova ; 109(10 Suppl 2): 57-9, 2009.
Article in Russian | MEDLINE | ID: mdl-20229635

ABSTRACT

Based on register data, epidemiologic indicators of cerebral stroke for the population of Khanty-Mansiysk autonomic okrug and values of early mortality and mean ages of patients have been obtained. The structure of acute disturbances of brain blood circulation has been studied. It has been shown that morbidity and mortality from cerebral stroke in the population of autonomic okrug is significantly lower compared to the same indicators in the Russian Federation in whole. Morbidity among men is higher than among women. An analysis of stroke risk factors revealed that the prevalence of some factors is significantly higher in the population of the okrug compared to other the Russian regions.


Subject(s)
Population Surveillance/methods , Registries , Stroke/epidemiology , Adult , Female , Humans , Male , Morbidity/trends , Retrospective Studies , Risk Factors , Russia/epidemiology
4.
Urologiia ; (5): 21-5, 2005.
Article in Russian | MEDLINE | ID: mdl-16281834

ABSTRACT

We compared efficacy of preoperative prophylactic antibiotic treatment (PPAT) with cyprofloxacine used orally (0.5 g), intravenously (0.4 g) and routine antibiotics in TUR of the prostate. A multicenter open randomized study covered 120 patients. PPAT efficacy was estimated by the rate of urinary infection (UI), frequency and duration of antibiotic treatment in the postoperative period, hospitalization duration. All the patients were divided into three groups: 39 patients of group 1 received oral cyprofloxacine 90-120 min before TUR of the prostate, 38 patients of group 2 received intravenous cyprofloxacine 30-60 min before TUR, 43 patients of group 3 (control) received routine antibiotic prophylaxis. The following results were obtained: 24-48 hours after the operation no cases of UI in group 1, 11.5 and 11.6% in groups 2 and 3, respectively, (p = 0.048); 7 days after TUR--UI in all the groups (2.6, 20, 23.3%, respectively); 14 days after TUR--UI in 5.1, 28.6, 27.9% patients, respectively. Mean duration of hospital stay was 11.7 +/- 7.6 days in group 1, 12.1 +/- 8.1 days in group 2, 12.5 +/- 7.8 days in group C (p > 0.05). Postoperative antibiotics were given to 16.7, 34.1 and 68.9% patients, respectively. Thus, cyprofloxacine in group 1 lowered UI risk and postoperative antibiotics significantly, in group 2 it had no influence on UI rate but reduced postoperative antibiotics significantly.


Subject(s)
Anti-Infective Agents/therapeutic use , Antibiotic Prophylaxis , Ciprofloxacin/therapeutic use , Postoperative Complications/prevention & control , Prostatic Hyperplasia/surgery , Urinary Tract Infections/prevention & control , Administration, Oral , Aged , Anti-Infective Agents/administration & dosage , Ciprofloxacin/administration & dosage , Humans , Injections, Intravenous , Male , Middle Aged , Prostate/surgery , Transurethral Resection of Prostate
5.
Urologiia ; (2): 13-7, 2004.
Article in Russian | MEDLINE | ID: mdl-15114744

ABSTRACT

AIM: To study causative agents and sensitivity of E-coli strains isolated from adult outpatients with uncomplicated urinary infection (UI) in different regions of Russia. MATERIAL AND METHODS: A multicenter prospective epidemiological study included adult patients with uncomplicated infections of the upper or lower urinary tracts. MPK of antibiotics was established by dilution in agar according to NCCLS recommendations, 2000-2002. RESULTS: Among UI causative agents, E. coli was most frequent (85.9%). K. Pneumoniae, Proteus spp., Staphylococcus spp., P. Aeruginosa, Enterococcus spp. occurred much less frequently (6, 1.8, 1.6, 1.2, and 1.0%, respectively). E. Coli UI was highly resistant to ampicilline (37.1%), cotrimoxasol (21%), maximal resistance being in St-Petersburg (51.9 and 31.5%, respectively). Such oral antibiotics as norfloxacin and ciprofloxacin, cefuroxim, amoxicillin/clavulanat, nitrofurantoin were maximally active against E. Coli (4.3, 2.4, 2.6 and 1.2%, respectively). CONCLUSION: High resistance of E. coli, which is the chief causative agent of uncomplicated UI, to ampicillin, cotrimoxasol was detected. Fluoroquinolones, amoxicillin/clavulanat, nitrofurantoin, cefuroxim have high microbiological activity. On the basis of the pharmacokinetic, safety and other evidence it is concluded that drugs of choice for therapy of uncomplicated UI in Russia are oral fluoroquinolones.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Infections/microbiology , Cystitis/microbiology , Drug Resistance, Bacterial/drug effects , Pyelonephritis/microbiology , Urine/microbiology , Ambulatory Care , Bacterial Infections/epidemiology , Cystitis/epidemiology , Humans , Microbial Sensitivity Tests , Prospective Studies , Pyelonephritis/epidemiology , Russia/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...